Ignite Creation Date:
2025-12-25 @ 4:37 AM
Ignite Modification Date:
2026-05-03 @ 6:54 PM
Study NCT ID:
NCT06090318
Status:
WITHDRAWN
Last Update Posted:
2023-10-19
First Post:
2022-11-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss
Sponsor:
Organization: